Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 24001 | Bomedemstat | 1990504-34-1 | ≧98.0% |  |
| Bomedemstat is anorally available, irreversible inhibitor of lysine-specific demethyl | ||||
| 218701 | TOVINONTRINE ( IMR-687 ) | 2062661-53-2 | ≧98.0% | _2062661-53-2.gif) |
| TOVINONTRINE ( IMR-687 ) is a highly selective and potent small molecule inhibitor of | ||||
| 20471 | FHD-286 | 2671128-05-3 | ≧98.0% |  |
| FHD-286 is an oral, small-molecule, selective, allosteric inhibitor of BRG1 and BRM i | ||||
| 2073104 | Enarodustat ( JTZ-951 ) | 1262132-81-9 | 98% Min. | _1262132-81-9.png) |
| Enarodustat ( JTZ-951 ) is an orally-active HIF-PH inhibitor with an EC50 of 0.22 Μm | ||||
| 24017 | AMG-193 | 2790567-82-5 | 98.62%; EE 98.28% |  |
| AMG-193 is an oral, small-molecule, methylthioadenosine-cooperative inhibitor of the | ||||
| 111895 | Oteseconazole | 1340593-59-0 | ≧98.0% |  |
| Oteseconazole, also known as VT-1161,is the first Approved Orally Bioavailable and Se | ||||
| 20638 | ATH434 mesylate | 2387898-69-1 | ≧98.0% |  |
| ATH434, is an oral agent designed to inhibit the aggregation of pathological proteins | ||||
| 17031303 | Tirabrutinib free base ( ONO-4059 ) | 1351636-18-4 | ≧98.0% | _1351636-18-4.png) |
| Tirabrutinib, also known as ONO-4059 is a potent and orally active Bruton agammaglobu | ||||
| 20549 | STC-15 | 2648257-56-9 | ≧98.0% |  |
| STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me | ||||
| 17012103 | Tirabrutinib HCl | 1439901-97-9 | ≧98.0% |  |
| ONO-4059 is a selective and novel inhibitor of BTK with IC50 2.2 nm, ONO-4059 binds t | ||||
| 23122601 | Navacaprant ( BTRX-335140 ) | 2244614-14-8 | ≧98.0% | _2244614-14-8.png) |
| Navacaprant (NMRA-335140, BTRX-140) is an oral, selective, reversible, small-molecule | ||||
| 181121 | AZD-5904 | 618913-30-7 | ≧98.0% |  |
| AZD5904 is a potent orally bioavailable MPO inhibitor. In preclinical studies, AZD590 | ||||